DongKoo Bio&Pharma logo

DongKoo Bio&Pharma

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

DongKoo Bio&Pharma produces and sells active probiotics, gum disease, and other products.

Investor Profile

DongKoo Bio&Pharma has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Corporate Round rounds (top funding stages).
  • Majority of deals are located in South Korea, United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Seed (25%)
  • Corporate Round (25%)

Country Focus

  • South Korea (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Therapeutics
  • Life Science
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DongKoo Bio&Pharma frequently co-invest with?

OP
North America, Delaware, United States, Dover
Co-Investments: 1
D&D Pharmatech
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
LB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Smilegate Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 2
Geon Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 2
OL
Asia, Maharashtra, India, Mumbai
Co-Investments: 2
Maryland Venture Fund
North America, Maryland, United States, Columbia
Co-Investments: 2
InterVest Co.
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
I
North America, Washington, United States, Kirkland
Co-Investments: 1
Magna Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2

What are some of recent deals done by DongKoo Bio&Pharma?

Picoentech

Seongnam, Kyonggi-do, South Korea

Picoentech is a biotechnology company that specializes in ARC (Accumulated-aldehyde Reducing Compounds) technology to delay ageing.

BiotechnologyLife ScienceProduct Research
Corporate RoundAug 5, 2024
Amount Raised: $876,634
Valted Seq

Gaithersburg, Maryland, United States

Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
SeedNov 2, 2021
Amount Raised: $10,000,000
Neuraly

Germantown, Maryland, United States

Neuraly is a startup biotech company.

BiotechnologyHealth Care
Series AJul 18, 2018
Amount Raised: $36,000,000
D&D Pharmatech

Seongnam, Kyonggi-do, South Korea

D&D Pharmatech is a Health care Company.

BiotechnologyHealth CarePharmaceutical
Series AJan 1, 2018
Amount Raised: $36,000,000